April 26, 2021 · Leave a Comment
Catch up on some of the news about Mayo Clinic’s research and faculty experts. Among the topics covered are artificial intelligence, women’s sexual health, genetic implications for several conditions, and COVID-19. AI caught a hidden problem in one patient’s heart. Can it work for others? STAT 4/26/2021 … Specifically, the algorithm, created by physicians at […]
Tags: AFib, amyloidosis, antiplatelet, artificial intelligence, atrial fibrillation, Center for the Science of Health Care Delivery, Charanjit Rihal, colorectal cancer, COVID-19, Dawn Marie Davis, dermatology, Donald Hensrud
September 3, 2020 · Leave a Comment
Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement― nonsurgical procedures to improve blood flow to the heart ― are typically prescribed anti-platelet therapy to avoid blood clots that can lead to a heart attack or stroke. New research from the international TAILOR-PCI trial, the largest pharmacogenetics clinical trial in cardiology, suggests that genetic testing could […]
Tags: antiplatelet, cardiology, Center for Individualized Medicine, Charanjit Rihal, clinical trials, coronary artery disease, gene variant, genetics, heart disease, Kent Bailey, Michael Farkouh, Naveen Pereira
August 8, 2019 · Leave a Comment
From the earliest days, physicians and scientists have flocked to Mayo Clinic from all over the world to learn. Today is no different. Thousands of international physicians and scientists have trained or worked at Mayo Clinic. Here are the stories of two Mayo Clinic scientists who came to Mayo from opposite sides of the globe.